Oncoustics AI
Edwina Alias is a skilled Biomedical Data Scientist currently employed at Oncoustics since September 2022. Previously, Edwina worked as a Data Scientist at SPACE (MedTech) Pte. Ltd. from April 2021 to June 2022, and as a Research Associate at Nanyang Technological University from April 2017 to March 2020. Edwina also held positions as Technical Manager and Data Engineer at Uvionics Tech (Thoughts 2 Solutions) from May 2015 to February 2017, and served as an Assistant Professor in the Electronics and Communication Engineering Department at Mar Athanasius College of Engineering for a brief period in 2015. Edwina holds a Master’s Degree in Signal Processing from Mahatma Gandhi University in Kerala, India, obtained between 2012 and 2014.
Oncoustics AI
Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.